Global Market Presence International HIFU has established a strong international footprint with treatment centers across multiple countries, including North America, Europe, Asia, and South America, presenting opportunities to expand into new markets and regions interested in prostate cancer treatments.

Niche Oncology Focus The company's focus on HIFU technology for prostate cancer positions it within a specialized, high-growth segment of minimally invasive oncology solutions, ideal for targeting healthcare providers seeking advanced treatment options.

Emerging U.S. Access With U.S. treatment centers supporting patient access to HIFU technology, there is a potential to increase sales by partnering with more U.S. healthcare providers or expanding outpatient facility integrations.

Limited Revenue Scale Despite its global reach, the company's current revenue of under one million dollars suggests significant growth opportunity through increased sales efforts, broader marketing, or expanding product usage among existing and new clients.

Partnership & Expansion As a subsidiary of SonaCare Medical, LLC, International HIFU can leverage parent company networks and resources to accelerate product adoption, explore new partnerships, and scale its presence within the high-demand minimally invasive therapy market.